{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:18:41Z","timestamp":1770484721759,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/maj.0b013e31824184b1","type":"journal-article","created":{"date-parts":[[2012,1,7]],"date-time":"2012-01-07T12:44:43Z","timestamp":1325940283000},"page":"345-349","source":"Crossref","is-referenced-by-count":20,"title":["Epoprostenol-Induced Hypersplenism in Portopulmonary Hypertension"],"prefix":"10.1016","volume":"344","author":[{"given":"Ravi P.","family":"Nayak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce R.","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh C.","family":"Kudva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem","family":"Touma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulfiqar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e31824184b1_bb0005","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0010","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary hypertension: results from a 10-year screening algorithm","volume":"44","author":"Krowka","year":"2006","journal-title":"Hepatology"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0015","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/lt.500030503","article-title":"Severe pulmonary hypertension in liver transplant candidates","volume":"3","author":"Ramsay","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0020","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1378\/chest.123.2.562","article-title":"Portopulmonary hypertension: a tale of two circulations","volume":"123","author":"Budhiraja","year":"2003","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jhep.2003.50060","article-title":"Diagnosis of portopulmonaryhypertension in candidates for liver transplantation: a prospective study","volume":"37","author":"Colle","year":"2003","journal-title":"Hepatology"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0030","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00007890-200102270-00015","article-title":"Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates","volume":"71","author":"Torregrosa","year":"2001","journal-title":"Transplantation"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4065\/71.6.543","article-title":"Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients","volume":"71","author":"Castro","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0735-1097(10)80121-4","article-title":"Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations","volume":"17","author":"Robalino","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0045","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.transproceed.2009.06.178","article-title":"The prevalence and the impact of portopulmonary hypertension on postoperative course inpatients undergoing liver transplantation","volume":"41","author":"Bozbas","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/lt.20016","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database","volume":"10","author":"Krowka","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jlts.2000.6356","article-title":"Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/lt.500050517","article-title":"Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension","volume":"5","author":"Findlay","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11894-009-0009-3","article-title":"Portopulmonary hypertension","volume":"11","author":"Nayak","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ajh.21600","article-title":"Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility","volume":"85","author":"Klco","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0075","first-page":"981","article-title":"Chronic idiopathic thrombocytopenic purpura. Splenic pathologic features and their clinical correlation","volume":"117","author":"Chang","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4166\/kjg.2009.54.3.143","article-title":"Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension","volume":"54","author":"Kim","year":"2009","journal-title":"Korean J Gastroenterol"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0085","first-page":"290","article-title":"Prostacyclin production in acute, chronic and long-term experimental portal hypertension","volume":"115","author":"Sitzman","year":"1994","journal-title":"Surgery"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0090","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI112101","article-title":"Effect of prostacyclin on vascular capacity in the dog","volume":"76","author":"Fulghum","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1681.2006.04328.x","article-title":"Prostacyclin causes splenic dilation and haematological change in dogs","volume":"33","author":"Noguchi","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0100","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/01.CIR.90.4.1643","article-title":"Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system","volume":"90","author":"Nakagawa","year":"1994","journal-title":"Circulation"},{"issue":"10 Suppl 1 Pt l\u20132","key":"10.1097\/MAJ.0b013e31824184b1_bb0105","first-page":"87b","article-title":"Thrombocytopenia during epoprostenol infusion for primary pulmonary hypertension: is there arelation to dose?","volume":"92","author":"Mow","year":"1998","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0110","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1378\/chest.118.4.1229","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus","volume":"118","author":"Horn","year":"2000","journal-title":"Chest"},{"issue":"4 Suppl","key":"10.1097\/MAJ.0b013e31824184b1_bb0115","doi-asserted-by":"crossref","first-page":"760S","DOI":"10.1378\/chest.126.4_MeetingAbstracts.760S-b","article-title":"Thrombocytopenia associated with chronic intravenous epoprostenol therapy","volume":"126","author":"Hargett","year":"2004","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1378\/chest.08-1323","article-title":"Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension","volume":"135","author":"Chin","year":"2009","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0125","first-page":"A3340","article-title":"Thrombocytopenia in PAH patient improves with transition from IV epoprostenol to IV treprostinil","volume":"181","author":"Mituniewicz","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl I","key":"10.1097\/MAJ.0b013e31824184b1_bb0130","first-page":"134","article-title":"Thrombocytopenia during chronic prostacyclin infusions in primary pulmonary hypertension","volume":"96","author":"Tokarczyk","year":"1997","journal-title":"Circulation"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0135","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood.V90.3.1039","article-title":"Expression of prostacyclin receptor in human megakaryocytes","volume":"90","author":"Sasaki","year":"1997","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jcp.1041630327","article-title":"Cyclic-AMP inhibits cell growth and negatively interacts with platelet membrane glycoprotein expression on the Dami human megakaryoblastic cell line","volume":"163","author":"Vittet","year":"1995","journal-title":"J Cell Physiol"},{"key":"10.1097\/MAJ.0b013e31824184b1_bb0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.prostaglandins.2007.01.012","article-title":"The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythro-leukemia cells","volume":"83","author":"Shen","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296291530803X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296291530803X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T11:37:37Z","timestamp":1593517057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296291530803X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S000296291530803X"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e31824184b1","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}